← All medicines

Cancer medicines

Idarubicin injection

Independent educational summary · Sources checked November 20, 2026

An anthracycline chemotherapy medicine used for specified leukemia treatment.

Profile scope: Idarubicin injection. Confirm the exact product and route; formulations and combination products are not interchangeable.

Possible side effects

Digestive symptoms, mouth soreness, headache, or hair shedding may occur.

Serious risks and warning signs

Serious heart injury can arise during treatment or much later. Infusion leakage can damage tissue. Severe infection, bleeding, neurological symptoms, or metabolic problems need urgent assessment. Additional cancers are a concern.

A question for your healthcare team

What heart and blood monitoring is required during and after treatment, and which infusion-site or delayed symptoms need immediate contact?

What to do with this information

Discuss persistent or troubling symptoms with your prescriber or pharmacist. For severe breathing difficulty, collapse, a seizure, or inability to wake someone, seek emergency help. Read the linked medicine information for drug-specific instructions, including situations requiring immediate action. For routine treatment changes, consult your prescriber rather than changing your dose on your own. Follow the urgent action instructions above and in the linked medicine information.

Sources

Sources checked November 20, 2026. An original AI-assisted educational summary, not a complete adverse-effect or interaction list. This profile is part of the broader library expansion, not the original prescription-use ranking. Inclusion does not confirm current product availability or mean that risks outweigh benefits. This page has not been independently reviewed by a clinician.